CoChat

Antiepileptic effects of levetiracetam in a rodent neonatal seizure model

Open access
Talos, Delia M., Chang, Meayoung, Kosaras, Bela, Fitzgerald, Erin, Murphy, Andrew, Folkerth, Rebecca Dunn, Jensen, Frances E. · 2013 · Pediatric Research
Cited by 56

The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.

Abstract

Background:Neonatal seizures can result in chronic epilepsy and long-term behavioral and cognitive deficits. Levetiracetam (LEV), an antiepileptic drug that binds to the synaptic vesicle protein 2A (SV2A), has been increasingly used off-label for the therapy of neonatal seizures. Preclinical data regarding the acute or long-term efficacy of LEV are lacking.Methods:We tested the anticonvulsant efficacy of LEV in a rat model of hypoxia-induced neonatal seizures. In addition, we evaluated the protective effects of postnatal day (P)10 LEV treatment on later-life kainic acid (KA)–induced seizure susceptibility and seizure-induced neuronal injury. Western blot and immunohistochemistry were used to assess the developmental regulation of SV2A in the rat and human brain.Results:LEV pretreatment at P10 significantly decreased the cumulative duration of behavioral and electrographic seizures at both 25 and 50 mg/kg. At P40, KA-induced seizures and neuronal loss were significantly diminished in rats previously treated with LEV. LEV target SV2A is present in both neonatal rat and human brain and increases steadily to adulthood.Conclusion:LEV suppressed acute seizures induced by perinatal hypoxia and diminished later-life seizure susceptibility and seizure-induced neuronal injury, providing evidence for disease modification. These results support consideration of a clinical trial of LEV in neonatal seizures.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/pr.2012.151

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 1 references

Cited by

  • Levetiracetam Mechanisms of Action: From Molecules to Systems

    Contreras-García, I. J., Cárdenas-Rodríguez, N., Romo-Mancillas, A., Bandala, C., Zamudio, S. R., Gómez-Manzo, S., Hernández-Ochoa, B., Mendoza-Torreblanca, J. G., & Pichardo-Macías, L. A. (2022) · Pharmaceuticals · doi:10.3390/ph15040475 · Cited by 131

    “LEV was also effective in animal models of chronic epilepsy, including genetic models (Genetic Absence Epilepsy Rat from Strasbourg, GAERS) and WAG/Rij rats [209,210], as well as in a rodent model of neonatal hypoxic seizures, where LEV pretreatment (50 mg/kg) resulted in a decrease in both behavioral seizure duration…”
  • Treatment during a vulnerable developmental period rescues a genetic epilepsy

    Marguet, S. L., Le-Schulte, V. T. Q., Merseburg, A., Neu, A., Eichler, R., Jakovcevski, I., Ivanov, A., Hanganu-Opatz, I. L., Bernard, C., Morellini, F., et al. (2015) · Nature Medicine · doi:10.1038/nm.3987 · Cited by 125

  • Synaptic Vesicle Glycoprotein 2A: Features and Functions

    Rossi, R., Arjmand, S., Bærentzen, S. L., Gjedde, A., & Landau, A. M. (2022) · Frontiers in Neuroscience · doi:10.3389/fnins.2022.864514 · Cited by 123

    “…mediation of vesicular entry of neurotoxins, interaction with adenine nucleotides and mitochondrial localization and role as fusion or fission factor. levetiracetam has an anticonvulsant effect that renders longterm protection against behavioral seizures and neuronal injury (Talos et al., 2013).”
    Background

See all 56

Metadata

Authors
Talos, D. M., Chang, M., Kosaras, B., Fitzgerald, E., Murphy, A., Folkerth, R. D., & Jensen, F. E.
Venue
Pediatric Research
Published
2012-11-08
Volume
73
Issue
1
Pages
24-30
ISSN
  • 0031-3998 (ISSN-L)
  • 1530-0447
OpenAlex
W2039212493
Cited by
56
References
1
FWCI
2.05
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Antiepileptic effects of levetiracetam in a rodent neonatal seizure model. https://app.cochat.ai/papers/10.1038/pr.2012.151
The paper
Talos, D. M., Chang, M., Kosaras, B., Fitzgerald, E., Murphy, A., Folkerth, R. D., & Jensen, F. E. (2013). Antiepileptic effects of levetiracetam in a rodent neonatal seizure model. Pediatric Research. https://doi.org/10.1038/pr.2012.151

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.